Toward Precision Medicine in ADHD
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Attention-Deficit Hyperactivity Disorder (ADHD) is a complex and heterogeneous neurodevelopmental condition for which curative treatments are lacking. Whilst pharmacological treatments are generally effective and safe, there is considerable inter-individual variability among patients regarding treatment response, required dose, and tolerability. Many of the non-pharmacological treatments, which are preferred to drug-treatment by some patients, either lack efficacy for core symptoms or are associated with small effect sizes. No evidence-based decision tools are currently available to allocate pharmacological or psychosocial treatments based on the patient's clinical, environmental, cognitive, genetic, or biological characteristics. We systematically reviewed potential biomarkers that may help in diagnosing ADHD and/or stratifying ADHD into more homogeneous subgroups and/or predict clinical course, treatment response, and long-term outcome across the lifespan. Most work involved exploratory studies with cognitive, actigraphic and EEG diagnostic markers to predict ADHD, along with relatively few studies exploring markers to subtype ADHD and predict response to treatment. There is a critical need for multisite prospective carefully designed experimentally controlled or observational studies to identify biomarkers that index inter-individual variability and/or predict treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Karalunas, S. L., Fair, D., Musser, E. D., Aykes, K., Iyer, S. P., & Nigg, J. T. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.763 · Cited by 340 · cited 1×
“…differences in temperament and in particular by emotional regulation/dysregulation has been proposed as a promising way to parse the disorder’s clinical and cognitive heterogeneity and develop models to predict treatment response and course (Karalunas et al., 2014, 2019; Nigg et al., 2020).”
BackgroundRetractedThe worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Self-citationAn Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
Clinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., Fetcho, R. N., Zebley, B., Oathes, D. J., Etkin, A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4246 · Cited by 2,170 · cited 2×
“Attempts to define more biologically homogeneous subgroups (“biotypes”) (Drysdale et al., 2017) or pathophysiological dimensions of psychiatric disorders are under way (Cuthbert, 2014), but still have to deliver (Wium-Andersen et al.”
BackgroundThe Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,716 · cited 6×
“Children with associated tic disorders or autism spectrum disorder (ASD) also have a favorable response to stimulants (Bloch et al., 2009; Reichow et al., 2013).”
BackgroundInfluentialSelf-citationAttention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationCuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377 · cited 3×
“Attempts to define more biologically homogeneous subgroups (“biotypes”) (Drysdale et al., 2017) or pathophysiological dimensions of psychiatric disorders are under way (Cuthbert, 2014), but still have to deliver (Wium-Andersen et al., 2017).”
BackgroundGenetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338
Self-citation
Cited by
Attention-deficit/hyperactivity disorder
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00495-0 · Cited by 355
Self-citationDrug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Sex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
Self-citationRadonjić, N. V., Bellato, A., Khoury, N. M., Cortese, S., & Faraone, S. V. (2023) · CNS Drugs · doi:10.1007/s40263-023-01005-8 · Cited by 45
Vera, J. D., Freichel, R., Michelini, G., Loo, S. K., & Lenartowicz, A. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241253999 · Cited by 9
“This symptom-specific approach is congruent with current efforts in the domain of precision psychiatry to identify unique ADHD features that can be used to person-alize treatment and diagnosis (Buitelaar et al., 2022).”
Result
Metadata
- Authors
- Buitelaar, J., Bölte, S., Brandeis, D., Caye, A., Christmann, N., Cortese, S., Coghill, D., Faraone, S. V., Franke, B., Gleitz, M., Greven, C. U., Kooij, S., Leffa, D. T., Rommelse, N., Newcorn, J. H., Polanczyk, G. V., Rohde, L. A., Simonoff, E., Stein, M., Vitiello, B., Yazgan, Y., Roesler, M., Doepfner, M., & Banaschewski, T.
- Venue
- Frontiers in Behavioral Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2022-07-06
- Volume
- 16
- Pages
- 900981-900981
- ISSN
- 1662-5153 (ISSN-L)
- OpenAlex
- W4286630881
- Cited by
- 76
- References
- 75
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward Precision Medicine in ADHD. https://app.cochat.ai/papers/10.3389/fnbeh.2022.900981
- The paper
- Buitelaar, J., Bölte, S., Brandeis, D., Caye, A., Christmann, N., Cortese, S., Coghill, D., Faraone, S. V., Franke, B., Gleitz, M., Greven, C. U., Kooij, S., Leffa, D. T., Rommelse, N., Newcorn, J. H., Polanczyk, G. V., Rohde, L. A., Simonoff, E., Stein, M., . . . Banaschewski, T. (2022). Toward Precision Medicine in ADHD. Frontiers in Behavioral Neuroscience. https://doi.org/10.3389/fnbeh.2022.900981
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.